Table 2.

Key elements to be considered in choosing a screening strategy for high-resources settings.

Screening method	Cervical cytology or HPV DNA testing
Adjunct	HPV testing and colposcopy for abnormal cytology, colposcopy, and/or biopsy for those persistently HPV DNA(+)
Support	Colposcopy and treatment for CIN2+ and cancer
Age	Starting at 25 to 30 years old and ending at 65 years old
Interval	Once every 3 to 5 years
Screening Registry	Available
Cancer Registry	National, regional, and local level available